Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer—A preliminary report

This publication has 37 references indexed in Scilit:

• Enhanced Therapeutic Effect of HSV-tk+GCV Gene Therapy and Ionizing Radiation for Prostate Cancer
  Molecular Therapy, 2001
• Cancer statistics, 2000
  CA: A Cancer Journal for Clinicians, 2000
• In Situ Gene Therapy for Adenocarcinoma of the Prostate: A Phase I Clinical Trial
  Human Gene Therapy, 1999
• External beam radiotherapy dose response of prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1997
• Gene therapy for prostate cancer.
  British Journal of Urology, 1997
• Adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy leads to systemic activity against spontaneous and induced metastasis in an orthotopic mouse model of prostate cancer
  International Journal of Cancer, 1997
• Conformal technique dose escalation for prostate cancer: Biochemical evidence of improved cancer control with higher doses in patients with pretreatment prostate-specific antigen ≥10 ng/ml
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Prostate Cancer Gene Therapy: Herpes Simplex Virus Thymidine Kinase Gene Transduction Followed by Ganciclovir in Mouse and Human Prostate Cancer Models
  Human Gene Therapy, 1996
• Long-term treatment sequelae following external beam irradiation for adenocarcinoma of the prostate: analysis of RTOG studies 7506 and 7706
  International Journal of Radiation Oncology*Biology*Physics, 1991
• Late radiation damage in prostate cancer patients treated by high dose external radiotherapy in relation to rectal dose
  International Journal of Radiation Oncology*Biology*Physics, 1990